# Bolt Biotherapeutics, Inc.: Form 8-K, filed Oct 6, 2026

- Company: [Bolt Biotherapeutics, Inc.](/companies/bolt.md) (CIK 1641281)
- Form: 8-K
- Filed: 2026-10-06
- Accepted by EDGAR: Oct 6, 2026, 16:07 ET
- Period: 2026-10-01
- Accession: 0001193125-26-415560
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1641281/000119312526415560/bolt-20261001.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1641281/000119312526415560/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1641281/000119312526415560/bolt-20261001.htm

Filed Oct 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-415560. Last ingested by Listed: Nov 10, 2026, 22:49 ET. No prices; not investment advice.